Trading Symbol: HEB
CUSIP Number: 42366C103
TERMS OF THE SETTLEMENT: The Settlement consists of $3,600,000 in cash and will include interest on the Settlement Fund prior to distribution.
CLASS DESCRIPTION: On behalf of all persons who purchased or otherwise acquired Hemispherx Biopharma, Inc. common stock during the period of February 18, 2009 to December 01, 2009, inclusive.
IMPORTANT DATES:
DATE TO SEEK EXCLUSION
FROM THE CLASS: DECEMBER 29, 2010
DATE FOR SUBMISSION OF
PROOF OF CLAIM FORMS: FEBRUARY 19, 2011
Keine Kommentare:
Kommentar veröffentlichen